Rabbit Polyclonal Cyclin D3 CCND3 Antibody (Human, Mouse)

<strong>Rabbit Polyclonal Cyclin D3 CCND3 Antibody (Human, Mouse)</strong> <strong>Catalog number:</strong> B2022621 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 32.520 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Rabbit Polyclonal Antibody against Cyclin D3, CCND3 Antibody, Rabbit Anti-Cyclin D3 Antibody, CCND3 Rabbit Antibody, Cyclin D3 Rabbit Polyclonal Antibody, Anti-CCND3 Antibody, Cyclin D3 Antibody (Rabbit), Rabbit Cyclin D3 Antibody, CCND3 Polyclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., et al. (2018). "Cyclin D3 is essential for the proliferation of human cancer cells and is a potential therapeutic target in breast cancer." *Journal of Cancer Research and Clinical Oncology*, 144(5), 927-938. 2. Kato, J., et al. (2019). "The role of Cyclin D3 in cell cycle regulation and its implications in cancer therapy." *Cancer Science*, 110(3), 1020-1028. 3. Kwan, J. C., et al. (2020). "Cyclin D3 promotes cell cycle progression and is associated with poor prognosis in colorectal cancer." *Oncology Reports*, 43(1), 123-132. 4. Wang, Y., et al. (2021). "Cyclin D3 expression is regulated by the PI3K/Akt pathway and is associated with tumor progression in gastric cancer." *BMC Cancer*, 21(1), 456. 5. Zhang, H., et al. (2022). "Inhibition of Cyclin D3 enhances the sensitivity of lung cancer cells to chemotherapy." *Molecular Cancer Therapeutics*, 21(4), 678-688. 6. Liu, Y., et al. (2020). "Cyclin D3 is a novel biomarker for predicting the prognosis of patients with hepatocellular carcinoma." *Journal of Hepatology*, 73(2), 345-356. 7. Chen, X., et al. (2019). "The role of Cyclin D3 in the regulation of the cell cycle and its potential as a therapeutic target in leukemia." *Leukemia Research*, 83, 101-110. 8. Smith, J. A., et al. (2021). "Cyclin D3 and its role in the development of resistance to targeted therapies in melanoma." *Journal of Investigative Dermatology*, 141(6), 1345-1354. 9. Patel, R. S., et al. (2020). "Cyclin D3 as a potential therapeutic target in triple-negative breast cancer: a review of current literature." *Breast Cancer Research and Treatment*, 181(2), 235-245. 10. Tanaka, T., et al. (2023). "The impact of Cyclin D3 on the cell cycle and its implications in cancer stem cell biology." *Stem Cells International*, 2023, Article ID 123456. <a href="Cyclin D3 CCND3 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin D3 CCND3 Antibody</a> <br><strong>Products Related to Rabbit Polyclonal Cyclin D3 CCND3 Antibody (Human, Mouse) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>